用于细胞选择性基因组编辑的酶诱导CRISPR/Cas9的正交化学激活
Weiqi Cai1,2, Ji Liu1,2, Xianghan Chen1,2
1Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
Journal of the American Chemical Society
|November 11, 2022
概括
我们开发了酶诱导CRISPR (eiCRISPR), 这种新的方法使用与疾病相关的酶来控制Cas9的活性,使得向性基因治疗在癌细胞中成为可能.
科学领域:
- 生物技术
- 分子生物学
- 基因编辑
背景情况:
- CRISPR/Cas9基因组编辑精度受到DNA分裂控制的限制.
- 开发可控制的细胞选择性基因组编辑系统对于治疗应用至关重要.
研究的目的:
- 引入一种条件和细胞选择性基因组编辑系统,即酶诱导CRISPR (eiCRISPR).
- 通过利用与疾病相关的酶来激活癌细胞, 实现精确的基因组编辑.
主要方法:
- eiCRISPR系统包括Cas9蛋白,一个自我阻断的非活性单导向RNA (bsgRNA) 和一个化学封闭的脱氧酶 (DNAzyme).
- 通过瘤细胞过度表达的酶 (例如NQO1) 恢复DNA酶活性,激活bsgRNA和eCRISPR.
- 在携带瘤的异种移植模型中使用可生物降解的脂质纳米颗粒进行体内输送.
主要成果:
- 通过酶触发的eiCRISPR激活在癌细胞中的选择性基因组编辑.
- 在体内成功编辑了人类乳头瘤病毒18E6, 显示了癌症治疗的潜力.
- 展示了用于调节eiCRISPR的合成后和特定位点的DNA酶修饰.
结论:
- eiCRISPR提供了一个可控制的细胞选择性基因组编辑平台.
- 这种系统对基因治疗具有前景, 特别是在癌症治疗中.
- 该策略可用于调节使用内源化学的基因组编辑.
相关概念视频
CRISPR/Cas9 Genome Editing
142
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
142
CRISPR
52.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.7K
CRISPR and crRNAs
17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
Homologous Recombination
50.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.8K
Conservative Site-specific Recombination and Phase Variation
6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.1K


